201 ELLIOTT AVENUE WEST
SEATTLE WA 98119
Business Phone: 206-676-5000
• SEATTLE, WA How do I update this listing?
Omeros Corp is based out of Seattle. Omeros Corporation, a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing products on inflammation and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform, which is designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The company's lead PharmacoSurgery product candidate, OMS103HP, is in two Phase 3 clinical programs to improve postoperative joint function and reduce pain following arthroscopic anterior cruciate ligament reconstruction surgery, and to reduce pain and improve postoperative joint function following arthroscopic meniscectomy surgery. Its product candidates also include OMS302 for use during ophthalmological procedures, including cataract and other lens replacement surgery; and OMS201 for use during urological surgery, including uroendoscopic procedures of the bladder, ureter, urethra, and other urinary tract structures. The company's pre-clinical developmental programs comprise MASP-2 program, in which it is developing antibody therapies to treat disorders caused by complement activated inflammation; cartilage protective program to treat cartilage disorders, such as osteoarthritis and rheumatoid arthritis; and Phosphodiesterase 10 program for the treatment of schizophrenia; GPCR program to treat a series of CNS disorders. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.Whalewisdom has at least 109 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-10-27. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security